H. Parker
Chairman at SANGAMO THERAPEUTICS, INC.
Net worth: 216 568 $ as of 29/04/2024
Network origin in H. Parker first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA.
228
| College/University | Other Consumer Services | 228 |
| Public Company | Biotechnology | 59 | |
Immunex Corp.
 Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation
34
| Subsidiary | Biotechnology | 34 |
| Public Company | Chemicals: Specialty | 22 | |
| Public Company | Pharmaceuticals: Major | 17 | |
Global Partnerships
 Global Partnerships Financial ConglomeratesFinance Global Partnerships invests in partnerships with local organizations that use market-based solutions for people living in poverty. The firm invests in the areas such as health services, rural livelihoods, green technology and microentrepreneurship. The company was founded by Paula Clapp and Bill Clapp in 1994 and is headquartered in Seattle, WA.
17
| Non-Profit Organization | Financial Conglomerates | 17 |
| Public Company | Biotechnology | 16 | |
AmpliPhi Biosciences Corp.
 AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA.
16
| Extinct | Biotechnology | 16 |
StrideBio, Inc.
 StrideBio, Inc. BiotechnologyHealth Technology Stridebio, Inc. focuses on creating and developing novel adeno-associated viral vector technologies. The company was founded by Aravind Asokan, Mavis Agbandje-McKenna and Patrick Ritschel and is headquartered in Durham, NC.
12
| Holding Company | Biotechnology | 12 |
| Public Company | Pharmaceuticals: Major | 11 | |
Neose Technologies, Inc.
 Neose Technologies, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activity is to develop proprietary drugs, focusing primarily on therapeutic proteins. Its technologies to develop proprietary versions of protein drugs with proven safety and efficacy and to improve the therapeutic profiles of proteins being developed. Its proprietary drug development portfolio currently consists of two therapeutic protein candidates.GlycoPEG-EPO (NE-180) is a long-acting version of erythropoietin (EPO) produced in insect cells. EPO is prescribed to stimulate production of red blood cells, and it gives treatment of chemotherapy-induced anemia and anemia associated with chronic renal failure. Its second proprietary protein, GlycoPEG-GCSF, is a long-acting version of granulocyte colony stimulating factor G-CSF and it is prescribed to stimulate production of neutrophils (a type of white blood cell). Its trademarks are NEOSE, GlycoPEGylation and GlycoConjugation. It operates predominantly in the domestic market.
5
| Extinct | Pharmaceuticals: Major | 5 |
Inventprise LLC
 Inventprise LLC Pharmaceuticals: MajorHealth Technology Inventprise LLC is a private company that is developing vaccines against infectious diseases, with a focus on invasive pneumococcal disease, using their innovative platform technology. The company is based in Redmond, WA. The company also offers contract services in biologics, including process development, optimization, analytical services, and manufacturing from early clinical trials through commercialization. The company was founded by Subhash Vinayak Kapre, who has been the CEO since incorporation.
4
| Private Company | Pharmaceuticals: Major | 4 |
C3J Therapeutics, Inc.
 C3J Therapeutics, Inc. BiotechnologyHealth Technology C3J Therapeutics, Inc. operates as a biotechnology company. It focuses on the discovery and development of novel targeted antimicrobials-synthetic bacteriophage and antimicrobial peptides. The company was founded by Randal Eckert, Maxwell H. Anderson and Wenyuan Shi in 2005 and is headquartered in Marina del Rey, CA.
4
| Subsidiary | Biotechnology | 4 |
Infectious Disease Research Institute
 Infectious Disease Research Institute Miscellaneous Commercial ServicesCommercial Services Infectious Disease Research Institute operates as a innovative science to research and development company. It offers pipeline, adjuvants, vaccines, diagnostics and drugs products. The firm also provides manufacturing, analytical methods, stability studies, process and contact services. The company was founded by Steven G. Reed in 1993 and is headquartered in Seattle, WA.
4
| Private Company | Miscellaneous Commercial Services | 4 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to H. Parker via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal General Counsel Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| PONIARD PHARMACEUTICALS, INC. | Biotechnology | Chief Executive Officer Director of Finance/CFO | |
ID Biomedical Corp.
 ID Biomedical Corp. Medical SpecialtiesHealth Technology ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada. | Medical Specialties | Chairman President Chief Operating Officer | |
| ARIAD PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| ABAXIS INC | Medical Specialties | Director/Board Member Director of Finance/CFO | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| AMARIN CORPORATION PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chairman Chief Executive Officer | |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree Graduate Degree Graduate Degree | |
| University of California, Los Angeles | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree Undergraduate Degree | |
C3 Jian LLC
 C3 Jian LLC BiotechnologyHealth Technology C3 Jian, Inc. operates as a biotechnological research and development company. It provides development and commercialization of pathogen-specific and antimicrobials that treat and prevent diseases caused by microbial dysbiosis. The company is headquartered in Marina del Rey, CA. | Biotechnology | Director/Board Member Chief Executive Officer Chief Operating Officer Corporate Officer/Principal | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Corporate Officer/Principal Director/Board Member | |
| AIMMUNE THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| RESPONSE BIOMEDICAL CORP | Miscellaneous Commercial Services | Chairman Director/Board Member Chief Operating Officer | |
| Harvard Business School | College/University | Masters Business Admin Graduate Degree Masters Business Admin | |
| Stanford University | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
Global Partnerships (Private Equity)
 Global Partnerships (Private Equity) Investment ManagersFinance Global Partnerships (Private Equity)(Global Partnerships) is a private equity subsidiary of Global Partnerships firm founded in 1994. The firm is headquartered in Seattle, Washington. | Investment Managers | Chief Executive Officer Director/Board Member Private Equity Investor | |
Deloitte & Touche LLP
 Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor Corporate Officer/Principal | |
| University of California | College/University | Undergraduate Degree Graduate Degree | |
| Stanford Graduate School of Business | College/University | Masters Business Admin Corporate Officer/Principal | |
| Columbia Business School | College/University | Masters Business Admin Masters Business Admin | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Undergraduate Degree | |
Gen-Probe, Inc.
 Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Medical Specialties | Comptroller/Controller/Auditor Chief Tech/Sci/R&D Officer | |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Chairman Director/Board Member | |
The American Institute of Certified Public Accountants
 The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| HYPERION THERAPEUTICS INC | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
AVITA Medical Pty Ltd.
 AVITA Medical Pty Ltd. BiotechnologyHealth Technology Avita Medical Ltd. engages in the development and distribution of regenerative and respiratory medicine and treatments. It operates through the following segments: Asia Pacific, Europe, and Americas. The Asia Pacific, Europe, and Americas segments involve in the sale of RECELL Devices. The company is headquartered in Valencia, CA. | Biotechnology | Director/Board Member Chief Executive Officer | |
Bioscience Managers Pty Ltd.
 Bioscience Managers Pty Ltd. Investment ManagersFinance BioScience Managers Pty Ltd (Bioscience Managers) is a private equity & venture capital firm founded in 2003 by Jeremy Curnock Cook. The firm is headquartered in Melbourne, Australia. | Investment Managers | Director/Board Member Private Equity Investor | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Life Technologies Corp.
 Life Technologies Corp. Miscellaneous Commercial ServicesCommercial Services Life Technologies Corp. provides products in the areas of scientific research, genetic analysis and applied sciences. Its brands include Invitrogen, Applied Biosystems, Gibco, Molecular Probes, Noves, Ambion and Ion Torrent. The firm’s portfolio includes the most cited products and technologies in qPCR, capillary electrophoresis sequencing, nextgeneration sequencing, molecular diagnostics, forensics, cell culture and analysis, and agriculture research. The company was founded on November 21, 2008 and is headquartered in Carlsbad, CA. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
eGenesis, Inc.
 eGenesis, Inc. Miscellaneous Commercial ServicesCommercial Services eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
| RELYPSA INC | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
| INNOVIVA, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| The Rockefeller University | College/University | Corporate Officer/Principal Graduate Degree | |
Integrated Diagnostics, Inc.
 Integrated Diagnostics, Inc. Medical/Nursing ServicesHealth Services Integrated Diagnostics, Inc. operates as a molecular diagnostics firm. It develops diagnostics and measurement technologies that has a capability of measuring biomarkers for diagnosis and management of complex diseases. The company was founded by Jim Heath, David J. Galas, Leroy E. Hood, and Paul Edward Kearney and is headquartered Seattle, WA. | Medical/Nursing Services | Director/Board Member Director of Finance/CFO | |
FluGen, Inc.
 FluGen, Inc. Pharmaceuticals: MajorHealth Technology Flugen, Inc. develops and produces influenza vaccines. Its products include a live attenuated vaccine candidate, a cell-line technology that provides vaccine production efficiency and capacity, and a novel, vaccine-loaded intradermal delivery technology. The company was founded by Yoshihiro Kawaoka, Gabriele Neumann and Paul Radspinner in 2007 and is headquartered in Madison, WI. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Rosetta Capital Ltd.
 Rosetta Capital Ltd. Investment ManagersFinance Rosetta Capital Ltd (Rosetta Capital) is a venture capital firm is founded in 2001 by Jeremy Curnock Cook, Michael Forer and Jonathan Hepple. The firm is headquartered in London. | Investment Managers | Chairman Private Equity Investor | |
Program for Appropriate Technology in Health
 Program for Appropriate Technology in Health Miscellaneous Commercial ServicesCommercial Services Program for Appropriate Technology in Health provides social healthcare services. Its platform includes vaccines, drugs, diagnostics and devices. The firm offers treatment for malaria, pneumonia and diarrheal. The company was founded in 1977 and is headquartered in Seattle, WA. | Miscellaneous Commercial Services | Chief Executive Officer Chairman | |
| JAZZ PHARMACEUTICALS PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal |
Statistics
International
| United States | 42 |
| Canada | 3 |
| Ireland | 3 |
| China | 2 |
| Australia | 2 |
Sectoral
| Health Technology | 26 |
| Consumer Services | 10 |
| Commercial Services | 9 |
| Finance | 5 |
| Health Services | 3 |
Operational
| Director/Board Member | 476 |
| Corporate Officer/Principal | 184 |
| Independent Dir/Board Member | 137 |
| Chairman | 105 |
| Chief Executive Officer | 89 |
Most connected contacts
| Insiders | |
|---|---|
| Jeremy Curnock-Cook | 60 |
| Steven Gillis | 58 |
| William Ringo | 32 |
| Karen Smith | 29 |
| Michael Perry | 28 |
| Patrick Yang | 28 |
| Ali Satvat | 28 |
| Robert Carey | 23 |
| Dennis Wolf | 23 |
| Todd R. Patrick | 22 |
| Rahul Singhvi | 22 |
| Michael T. Galgon | 21 |
| Stephen Brown Davis | 20 |
| Sarah Schlesinger | 19 |
| Adrian Adams | 19 |
- Stock Market
- Insiders
- H. Parker
- Company connections
